Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × UNKNOWN × Pain × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

OTHER 58 INDUSTRY 22 NIH 6 NETWORK 3 OTHER_GOV 2 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 21 Stomach Neoplasms 14 Colorectal Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Rectal Neoplasms 7 Triple Negative Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Small Cell Lung Carcinoma 4 Lymphoma, Extranodal NK-T-Cell 4 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Brain Neoplasms 4 Neoplasms 3 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Vomiting 2 Sarcoma 2 Recurrence 2 Nasopharyngeal Carcinoma 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 HER2-positive Breast Cancer 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Lung 1 Radiation Injuries 1 Platinum-resistant Recurrent Ovarian Cancer 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pain 1 Ovarian Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00530764 2013-06-20

SPRAY

GWPharm

Phase 2 Completed

360 enrolled 18 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡